Form 8-K - Current report:
SEC Accession No. 0001493152-24-049281
Filing Date
2024-12-09
Accepted
2024-12-09 16:30:09
Documents
14
Period of Report
2024-12-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39539
  Complete submission text file 0001493152-24-049281.txt   266147

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocea-20241203.xsd EX-101.SCH 3849
3 XBRL DEFINITION FILE ocea-20241203_def.xml EX-101.DEF 30129
4 XBRL LABEL FILE ocea-20241203_lab.xml EX-101.LAB 36877
5 XBRL PRESENTATION FILE ocea-20241203_pre.xml EX-101.PRE 27152
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6010
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

EIN.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 241535471
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)